Request Trial
shutterstock_1348256303_pavel_kapysh
Pavel Kapysh / Shutterstock.com
21 January 2020MedTechEdward Pearcey

USPTO denies Edwards' MitraClip patent challenge

The US Patent and Trademark Office (USPTO) has denied an inter partes review petition from Edwards Lifesciences, which argued that certain claims relating to Abbott’s MitraClip mitral valve repair device are unpatentable.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
Oura targets Ultrahuman’s redesigned smart ring following import ban
29 October 2026   The Finnish wearable tech company strikes again after the Indian rival’s redesigned ring cleared US Customs, with one of Oura’s asserted patents issued just two days earlier.
MedTech
Meril turns the tables on Edwards with European patent revocation
29 October 2026   Despite earlier wins at the UPC and EPO, a key heart valve patent has been revoked on appeal, with the latest ruling highlighting diverging approaches to patent validity in Europe and raising questions ahead of a separate UPC appeal.
MedTech
HeartFlow targets AI cardiac imaging rival over patents and trade secrets
27 October 2026   The 179-page lawsuit alleges that a Boston-based company used patented technology and confidential information from former employees to develop a competing cardiac imaging product.


Editor's picks

In-house counsel rethink patent filing strategies as costs mount
In-house counsel
In-house counsel rethink patent filing strategies as costs mount
3 November 2026

Editor's picks

In-house counsel
In-house counsel rethink patent filing strategies as costs mount
3 November 2026

More features

In-house counsel rethink patent filing strategies as costs mount
Fenwick hires NY partner to advise on regulatory matters
UK unveils £1bn sector investment push after recent setbacks
Justice Joanna Smith appointed to interim High Court role as Sir Colin Birss replaces Sir Geoffrey Vos
Oura targets Ultrahuman’s redesigned smart ring following import ban
Weil collapse leaves IP talent facing uncertain future after major expansion
Meril turns the tables on Edwards with European patent revocation
Latham lands pharma and tech expert in London